These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22419371)

  • 1. Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses.
    Winkler C; Steingrube DS; Altermann W; Schlaf G; Max D; Kewitz S; Emmer A; Kornhuber M; Banning-Eichenseer U; Staege MS
    Cancer Immunol Immunother; 2012 Oct; 61(10):1769-79. PubMed ID: 22419371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Ewing sarcoma associated cancer/testis antigens.
    Mahlendorf DE; Staege MS
    Cancer Biol Ther; 2013 Mar; 14(3):254-61. PubMed ID: 23291981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.
    Baumforth KR; Birgersdotter A; Reynolds GM; Wei W; Kapatai G; Flavell JR; Kalk E; Piper K; Lee S; Machado L; Hadley K; Sundblad A; Sjoberg J; Bjorkholm M; Porwit AA; Yap LF; Teo S; Grundy RG; Young LS; Ernberg I; Woodman CB; Murray PG
    Am J Pathol; 2008 Jul; 173(1):195-204. PubMed ID: 18502823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
    Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
    Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.
    Morandi F; Chiesa S; Bocca P; Millo E; Salis A; Solari M; Pistoia V; Prigione I
    Neoplasia; 2006 Oct; 8(10):833-42. PubMed ID: 17032500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease.
    Su Z; Peluso MV; Raffegerst SH; Schendel DJ; Roskrow MA
    Eur J Immunol; 2001 Mar; 31(3):947-58. PubMed ID: 11241300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
    Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
    Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4.
    Cruz CR; Gerdemann U; Leen AM; Shafer JA; Ku S; Tzou B; Horton TM; Sheehan A; Copeland A; Younes A; Rooney CM; Heslop HE; Bollard CM
    Clin Cancer Res; 2011 Nov; 17(22):7058-66. PubMed ID: 21908573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
    Ercolak V; Paydas S; Bagir E; Ergin M; Seydaoglu G; Celik H; Yavu B; Tanriverdi K; Gunaldi M; Afsar CU; Duman BB
    Acta Haematol; 2015; 134(4):199-207. PubMed ID: 26044287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.
    Altvater B; Kailayangiri S; Theimann N; Ahlmann M; Farwick N; Chen C; Pscherer S; Neumann I; Mrachatz G; Hansmeier A; Hardes J; Gosheger G; Juergens H; Rossig C
    Cancer Immunol Immunother; 2014 Oct; 63(10):1047-60. PubMed ID: 24973179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies.
    Gottschalk S; Edwards OL; Sili U; Huls MH; Goltsova T; Davis AR; Heslop HE; Rooney CM
    Blood; 2003 Mar; 101(5):1905-12. PubMed ID: 12411306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.
    Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J
    Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
    Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL
    Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S
    Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
    J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma.
    Gahn B; Siller-Lopez F; Pirooz AD; Yvon E; Gottschalk S; Longnecker R; Brenner MK; Heslop HE; Aguilar-Cordova E; Rooney CM
    Int J Cancer; 2001 Sep; 93(5):706-13. PubMed ID: 11477583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-Deoxycytidine.
    Yan M; Himoudi N; Basu BP; Wallace R; Poon E; Adams S; Hasan F; Xue SA; Wilson N; Dalgleish A; Williams O; Anderson J
    Cancer Immunol Immunother; 2011 Sep; 60(9):1243-55. PubMed ID: 21553146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.